The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
The Pathogenesis of Ebola Virus Disease
Open accessAbstract
For almost 50 years, ebolaviruses and related filoviruses have been repeatedly reemerging across the vast equatorial belt of the African continent to cause epidemics of highly fatal hemorrhagic fever. The 2013-2015 West African epidemic, by far the most geographically extensive, most fatal, and longest lasting epidemic in Ebola's history, presented an enormous international public health challenge, but it also provided insights into Ebola's pathogenesis and natural history, clinical expression, treatment, prevention, and control. Growing understanding of ebolavirus pathogenetic mechanisms and important new clinical observations of the disease course provide fresh clues about prevention and treatment approaches. Although viral cytopathology and immune-mediated cell damage in ebolavirus disease often result in severe compromise of multiple organs, tissue repair and organ function recovery can be expected if patients receive supportive care with fluids and electrolytes; maintenance of oxygenation and tissue perfusion; and respiratory, renal, and cardiovascular support. Major challenges for managing future Ebola epidemics include establishment of early and aggressive epidemic control and earlier and better patient care and treatment in remote, resource-poor areas where Ebola typically reemerges. In addition, it will be important to further develop Ebola vaccines and to adopt policies for their use in epidemic and pre-epidemic situations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taylor, F., Toh, C.-H., Hoots, K., Wada, H., & Levi, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616068 · Cited by 2,285
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
Gire, S. K., Goba, A., Andersen, K. G., Sealfon, R. S. G., Park, D. J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., Dudas, G., et al. (2014) · Science · doi:10.1126/science.1259657 · Cited by 1,215
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Furuta, Y., Gowen, B. B., Takahashi, K., Shiraki, K., Smee, D. F., & Barnard, D. L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.015 · Cited by 1,072
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., et al. (2014) · Nature · doi:10.1038/nature13777 · Cited by 987
Henao-Restrepo, A. M., Longini, I. M., Egger, M., Dean, N. E., Edmunds, W. J., Camacho, A., Carroll, M. W., Doumbia, M., Draguez, B., Duraffour, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61117-5 · Cited by 793
Tissue factor and hemostasis [published erratum appears in Blood 1988 Apr;71(4):1178]
Nemerson, Y. (1988) · Blood · doi:10.1182/blood.v71.1.1.1 · Cited by 682
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Warren, T. K., Wells, J., Panchal, R. G., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Dong, L., Retterer, C. J., Eaton, B. P., Pegoraro, G., et al. (2014) · Nature · doi:10.1038/nature13027 · Cited by 610
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
Leroy, E. M., Epelboin, A., Mondonge, V., Pourrut, X., Gonzalez, J.-P., Muyembe-Tamfum, J.-J., & Formenty, P. (2009) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2008.0167 · Cited by 562
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
van Griensven, J., Edwards, T., de Lamballerie, X., Semple, M. G., Gallian, P., Baize, S., Horby, P. W., Raoul, H., Magassouba, N., Antierens, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1511812 · Cited by 536
Ecological dynamics of emerging bat virus spillover
Plowright, R. K., Eby, P., Hudson, P. J., Smith, I. L., Westcott, D., Bryden, W. L., Middleton, D., Reid, P. A., McFarlane, R. A., Martin, G., et al. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.2124 · Cited by 534
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
Schieffelin, J. S., Shaffer, J. G., Goba, A., Gbakie, M., Gire, S. K., Colubri, A., Sealfon, R. S. G., Kanneh, L., Moigboi, A., Momoh, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411680 · Cited by 530
Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites
Bausch, D. G., Towner, J. S., Dowell, S. F., Kaducu, F., Lukwiya, M., Sanchez, A., Nichol, S. T., Ksiazek, T. G., & Rollin, P. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/520545 · Cited by 522
Oestereich, L., Lüdtke, A., Wurr, S., Rieger, T., Muñoz-Fontela, C., & Günther, S. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.02.014 · Cited by 493
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
Sissoko, D., Laouenan, C., Folkesson, E., M’Lebing, A.-B., Beavogui, A.-H., Baize, S., Camara, A.-M., Maes, P., Shepherd, S., Danel, C., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001967 · Cited by 478
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477
Persistence of Ebola Virus in Ocular Fluid during Convalescence
Varkey, J. B., Shantha, J. G., Crozier, I., Kraft, C. S., Lyon, G. M., Mehta, A. K., Kumar, G., Smith, J. R., Kainulainen, M. H., Whitmer, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500306 · Cited by 470
Bwaka, M. A., Bonnet, M., Calain, P., Colebunders, R., De Roo, A., Guimard, Y., Katwiki, K. R., Kibadi, K., Kipasa, M. A., Kuvula, K. J., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514308 · Cited by 465
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463
Geisbert, T. W., Lee, A. C., Robbins, M., Geisbert, J. B., Honko, A. N., Sood, V., Johnson, J. C., de Jong, S., Tavakoli, I., Judge, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60357-1 · Cited by 463
The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995
Khan, A. S., Tshioko, F. K., Heymann, D. L., Le Guenno, B., Nabeth, P., Kerstiëns, B., Fleerackers, Y., Kilmarx, P. H., Rodier, G. R., Nkuku, O., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514306 · Cited by 463
Cárdenas, W. B., Loo, Y.-M., Gale, M., Hartman, A. L., Kimberlin, C. R., Martínez-Sobrido, L., Saphire, E. O., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02199-05 · Cited by 453
Molecular Evidence of Sexual Transmission of Ebola Virus
Mate, S. E., Kugelman, J. R., Nyenswah, T. G., Ladner, J. T., Wiley, M. R., Cordier-Lassalle, T., Christie, A., Schroth, G. P., Gross, S. M., Davies-Wayne, G. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509773 · Cited by 434
Discovery of an Ebolavirus-Like Filovirus in Europe
Negredo, A., Palacios, G., Vázquez-Morón, S., González, F., Dopazo, H., Molero, F., Juste, J., Quetglas, J., Savji, N., de la Cruz Martínez, M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002304 · Cited by 431
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., Muyembe‐Tamfum, J. J., & the International Scientific and Technical Committee (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 420
Nabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Mapping the zoonotic niche of Ebola virus disease in Africa
Pigott, D. M., Golding, N., Mylne, A., Huang, Z., Henry, A. J., Weiss, D. J., Brady, O. J., Kraemer, M. U., Smith, D. L., Moyes, C. L., et al. (2014) · eLife · doi:10.7554/elife.04395 · Cited by 405
Dowell, S. F., Mukunu, R., Ksiazek, T. G., Khan, A. S., Rollin, P. E., Peters, C. J., & the Commission de Lutte contre les Epidémies à Kikwit (1999) · The Journal of Infectious Diseases · doi:10.1086/514284 · Cited by 398
Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells.
Conway, E. M., & Rosenberg, R. D. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.12.5588 · Cited by 390
Rowe, A. K., Bertolli, J., Khan, A. S., Mukunu, R., Muyembe‐Tamfum, J. J., Bressler, D., Williams, A. J., Peters, C. J., Rodriguez, L., Feldmann, H., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514318 · Cited by 387
Self-citationGeisbert, T. W., Hensley, L. E., Jahrling, P. B., Larsen, T., Geisbert, J. B., Paragas, J., Young, H. A., Fredeking, T. M., Rote, W. E., & Vlasuk, G. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15012-x · Cited by 382
Wauquier, N., Becquart, P., Padilla, C., Baize, S., & Leroy, E. M. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000837 · Cited by 377
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report
Deen, G. F., Broutet, N., Xu, W., Knust, B., Sesay, F. R., McDonald, S. L. R., Ervin, E., Marrinan, J. E., Gaillard, P., Habib, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1511410 · Cited by 375
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/379724 · Cited by 372
Clinical Management of Ebola Virus Disease in the United States and Europe
Uyeki, T. M., Mehta, A. K., Davey, R. T., Liddell, A. M., Wolf, T., Vetter, P., Schmiedel, S., Grünewald, T., Jacobs, M., Arribas, J. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504874 · Cited by 368
Late Ebola virus relapse causing meningoencephalitis: a case report
Jacobs, M., Rodger, A., Bell, D. J., Bhagani, S., Cropley, I., Filipe, A., Gifford, R. J., Hopkins, S., Hughes, J., Jabeen, F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30386-5 · Cited by 361
Ksiazek, T. G., Rollin, P. E., Williams, A. J., Bressler, D. S., Martin, M. L., Swanepoel, R., Burt, F. J., Leman, P. A., Khan, A. S., Rowe, A. K., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514321 · Cited by 359
Ebola Virus Disease in West Africa — Clinical Manifestations and Management
Chertow, D. S., Kleine, C., Edwards, J. K., Scaini, R., Giuliani, R., & Sprecher, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1413084 · Cited by 350
Self-citationClinical Care of Two Patients with Ebola Virus Disease in the United States
Lyon, G. M., Mehta, A. K., Varkey, J. B., Brantly, K., Plyler, L., McElroy, A. K., Kraft, C. S., Towner, J. S., Spiropoulou, C., Ströher, U., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409838 · Cited by 337
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
Kortepeter, M. G., Bausch, D. G., & Bray, M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir299 · Cited by 328
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E., & Zaki, S. R. (2015) · The Journal of Pathology · doi:10.1002/path.4456 · Cited by 319
Assembling evidence for identifying reservoirs of infection
Viana, M., Mancy, R., Biek, R., Cleaveland, S., Cross, P. C., Lloyd-Smith, J. O., & Haydon, D. T. (2014) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2014.03.002 · Cited by 317
Rodriguez, L. L., De Roo, A., Guimard, Y., Trappier, S. G., Sanchez, A., Bressler, D., Williams, A. J., Rowe, A. K., Bertolli, J., Khan, A. S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514291 · Cited by 311
Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
Connolly, B. M., Steele, K. E., Davis, K. J., Geisbert, T. W., Kell, W. M., Jaax, N. K., & Jahrling, P. B. (1999) · The Journal of Infectious Diseases · doi:10.1086/514305 · Cited by 308
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity
Neumann, F.-J., Ott, I., Marx, N., Luther, T., Kenngott, S., Gawaz, M., Kotzsch, M., & Schömig, A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3399 · Cited by 308
Filoviruses in Bats: Current Knowledge and Future Directions
Olival, K., & Hayman, D. (2014) · Viruses · doi:10.3390/v6041759 · Cited by 307
Villinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307
Human Ebola virus infection results in substantial immune activation
McElroy, A. K., Akondy, R. S., Davis, C. W., Ellebedy, A. H., Mehta, A. K., Kraft, C. S., Lyon, G. M., Ribner, B. S., Varkey, J., Sidney, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502619112 · Cited by 306
A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia
Kreuels, B., Wichmann, D., Emmerich, P., Schmidt-Chanasit, J., de Heer, G., Kluge, S., Sow, A., Renné, T., Günther, S., Lohse, A. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411677 · Cited by 302
Natural killer cell cytotoxicity: how do they pull the trigger?
Topham, N. J., & Hewitt, E. W. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03123.x · Cited by 298
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance
Rasmussen, A. L., Okumura, A., Ferris, M. T., Green, R., Feldmann, F., Kelly, S. M., Scott, D. P., Safronetz, D., Haddock, E., LaCasse, R., et al. (2014) · Science · doi:10.1126/science.1259595 · Cited by 290
Self-citationSanchez, A., Lukwiya, M., Bausch, D., Mahanty, S., Sanchez, A. J., Wagoner, K. D., & Rollin, P. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10370-10377.2004 · Cited by 281
After Ebola in West Africa — Unpredictable Risks, Preventable Epidemics
WHO Ebola Response Team (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1513109 · Cited by 280
Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.
Johnson, E. D., Jaax, N., White, J., & Jahrling, P. B. (1995) · Europe PMC (PubMed Central) · Cited by 271
Hypocalcemia: A pervasive metabolic abnormality in the critically ill
Zivin, J. R., Gooley, T., Zager, R. A., & Ryan, M. J. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80116-5 · Cited by 263
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 256
Self-citationGeisbert, T. W., Hensley, L. E., Kagan, E., Yu, E. Z., Geisbert, J. B., Daddario‐DiCaprio, K., Fritz, E. A., Jahrling, P. B., McClintock, K., Phelps, J. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/504267 · Cited by 254
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus
Messaoudi, I., Amarasinghe, G. K., & Basler, C. F. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3524 · Cited by 247
Hensley, L. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00327-3 · Cited by 242
Xu, W., Edwards, M. R., Borek, D. M., Feagins, A. R., Mittal, A., Alinger, J. B., Berry, K. N., Yen, B., Hamilton, J., Brett, T. J., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.07.008 · Cited by 241
Zaki, S. R., Shieh, W., Greer, P. W., Goldsmith, C. S., Ferebee, T., Katshitshi, J., Tshioko, F. K., Bwaka, M. A., Swanepoel, R., Calain, P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514319 · Cited by 235
The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids
Palmer, R. M. J., Bridge, L., Foxwell, N. A., & Moncada, S. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14202.x · Cited by 231
Groseth, A., Feldmann, H., & Strong, J. E. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.08.001 · Cited by 231
Self-citationWolf, T., Kann, G., Becker, S., Stephan, C., Brodt, H.-R., de Leuw, P., Grünewald, T., Vogl, T., Kempf, V. A. J., Keppler, O. T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62384-9 · Cited by 230
Smither, S. J., Eastaugh, L. S., Steward, J. A., Nelson, M., Lenk, R. P., & Lever, M. S. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.01.012 · Cited by 228
The role of the Type I interferon response in the resistance of mice to filovirus infection
Bray, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1365 · Cited by 228
Molecular Determinants of Ebola Virus Virulence in Mice
Ebihara, H., Takada, A., Kobasa, D., Jones, S., Neumann, G., Theriault, S., Bray, M., Feldmann, H., & Kawaoka, Y. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020073 · Cited by 214
Self-citationHunt, L., Gupta-Wright, A., Simms, V., Tamba, F., Knott, V., Tamba, K., Heisenberg-Mansaray, S., Tamba, E., Sheriff, A., Conteh, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00144-9 · Cited by 204
Kraft, C. S., Hewlett, A. L., Koepsell, S., Winkler, A. M., Kratochvil, C. J., Larson, L., Varkey, J. B., Mehta, A. K., Lyon, G. M., Friedman-Moraco, R. J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ334 · Cited by 195
Nitric oxide induces oxidative stress and apoptosis in neuronal cells
Wei, T., Chen, C., Hou, J., Xin, W., & Mori, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00078-1 · Cited by 194
Pourrut, X., Délicat, A., Rollin, P. E., Ksiazek, T. G., Gonzalez, J. ‐., & Leroy, E. M. (2007) · The Journal of Infectious Diseases · doi:10.1086/520541 · Cited by 187
Transmission of Ebola virus from pigs to non-human primates
Weingartl, H. M., Embury-Hyatt, C., Nfon, C., Leung, A., Smith, G., & Kobinger, G. (2012) · Scientific Reports · doi:10.1038/srep00811 · Cited by 183
Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study
Mattia, J. G., Vandy, M. J., Chang, J. C., Platt, D. E., Dierberg, K., Bausch, D. G., Brooks, T., Conteh, S., Crozier, I., Fowler, R. A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00489-2 · Cited by 180
Jones, M. E. B., Schuh, A. J., Amman, B. R., Sealy, T. K., Zaki, S. R., Nichol, S. T., & Towner, J. S. (2015) · Viruses · doi:10.3390/v7072779 · Cited by 174
Long QT Syndrome: An Emerging Role for Inflammation and Immunity
Lazzerini, P. E., Capecchi, P. L., & Laghi-Pasini, F. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00026 · Cited by 172
Coagulation Abnormalities in Liver Disease
Mammen, E. F. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30273-9 · Cited by 171
Clinical features and pathobiology of Ebolavirus infection
Ansari, A. A. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.09.001 · Cited by 170
Filovirus Replication and Transcription
Mühlberger, E. (2007) · Future Virology · doi:10.2217/17460794.2.2.205 · Cited by 169
Assessing the Evidence Supporting Fruit Bats as the Primary Reservoirs for Ebola Viruses
Leendertz, S. A. J., Gogarten, J. F., Düx, A., Calvignac-Spencer, S., & Leendertz, F. H. (2016) · EcoHealth · doi:10.1007/s10393-015-1053-0 · Cited by 166
Pathologic Features of Filovirus Infections in Humans
Zaki, S. R., & Goldsmith, C. S. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59949-1_7 · Cited by 166
Ebola Hemorrhagic Fever and Pregnancy
Mupapa, K., Mukundu, W., Bwaka, M. A., Kipasa, M., De Roo, A., Kuvula, K., Kibadi, K., Massamba, M., Ndaberey, D., Colebunders, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514289 · Cited by 165
Structure of the Ebola VP35 interferon inhibitory domain
Leung, D. W., Ginder, N. D., Fulton, D. B., Nix, J. C., Basler, C. F., Honzatko, R. B., & Amarasinghe, G. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807854106 · Cited by 161
Ebola virus disease and critical illness
Leligdowicz, A., Fischer, W. A., Uyeki, T. M., Fletcher, T. E., Adhikari, N. K. J., Portella, G., Lamontagne, F., Clément, C., Jacob, S. T., Rubinson, L., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1325-2 · Cited by 160
Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever
Hensley, L. E., Stevens, E. L., Yan, S.-C. B., Geisbert, J. B., Macias, W. L., Larsen, T., Daddario-DiCaprio, K. M., Cassell, G. H., Jahrling, P. B., & Geisbert, T. W. (2007) · The Journal of Infectious Diseases · doi:10.1086/520598 · Cited by 157
Bray, M., Hatfill, S. J., Hensley, L. E., & Huggins, J. W. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0503 · Cited by 156
Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone
Tiffany, A., Vetter, P., Mattia, J. G., Dayer, J.-A., Bartsch, M., Kasztura, M., Sterk, E., Tijerino, A. M., Kaiser, L., & Ciglenečki, I. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw158 · Cited by 156
Ebola Virus Haemorrhagic Fever
Halstead, S. B. (1979) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1979.28.775 · Cited by 155
The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
Zhang, A. P. P., Bornholdt, Z. A., Liu, T., Abelson, D. M., Lee, D. E., Li, S., Woods, V. L., & Saphire, E. O. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002550 · Cited by 149
Rollin, P. E., Bausch, D. G., & Sanchez, A. (2007) · The Journal of Infectious Diseases · doi:10.1086/520613 · Cited by 149
Francica, J. R., Varela‐Rohena, A., Medvec, A. R., Plesa, G., Riley, J. L., & Bates, P. F. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001098 · Cited by 146
Molecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus
Volchkov, V. E., Chepurnov, A. A., Volchkova, V. A., Ternovoi, V. A., & Klenk, H. (2000) · Virology · doi:10.1006/viro.2000.0572 · Cited by 146
Mutation rate and genotype variation of Ebola virus from Mali case sequences
Hoenen, T., Safronetz, D., Groseth, A., Wollenberg, K. R., Koita, O., Diarra, B., Fall, I. S., Haidara, F. C., Diallo, F., Sanogo, M., et al. (2015) · Science · doi:10.1126/science.aaa5646 · Cited by 140
Self-citationReplication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs
Kobinger, G., Leung, A., Neufeld, J., Richardson, J. S., Falzarano, D., Smith, G. A., Tierney, K. J., Patel, A. R., & Weingartl, H. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir077 · Cited by 139
Kibadi, K., Mupapa, K., Kuvula, K., Massamba, M., Ndaberey, D., Muyembe‐Tamfum, J. J., Bwaka, M. A., Roo, A. D., & Colebunders, R. (1999) · The Journal of Infectious Diseases · doi:10.1086/514288 · Cited by 134
Burk, R., Bollinger, L., Johnson, J. C., Wada, J., Radoshitzky, S. R., Palacios, G. F., Bavari, S., Jahrling, P. B., & Kuhn, J. H. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw010 · Cited by 134
Isolation and Phylogenetic Characterization of Ebola Viruses Causing Different Outbreaks in Gabon
Georges-Courbot, M. C., Sanchez, A., Lu, C. Y., Baize, S., Leroy, E. M., Lansoud-Soukate, J., Tévi‐Bénissan, C., Georges, A. J., Trappier, S. G., Zaki, S. R., et al. (1997) · Emerging infectious diseases · doi:10.3201/eid0301.970107 · Cited by 133
Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
Vega, M.-A. D. L., Caleo, G., Audet, J., Qiu, X., Kozak, R. A., Brooks, J., Kern, S. E., Wolz, A., Sprecher, A., Greig, J. E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83162 · Cited by 131
A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever
Ebihara, H., Zivcec, M., Gardner, D. J., Falzarano, D., LaCasse, R. A., Rosenke, R., Long, D., Haddock, E., Fischer, E., Kawaoka, Y., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis626 · Cited by 128
Self-citationMora-Rillo, M., Arsuaga, M., Olivencia, G. R., Calle, F., Borobia, A. M., Sánchez-Seco, P., Lago, M., Figueira, J. C., Fernández-Puntero, B., Viejo, A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00180-0 · Cited by 128
Davis, K. J., Anderson, A. O., Geisbert, T. W., Steele, K. E., Geisbert, J. B., Vogel, P., Connolly, B., Huggins, J. W., Jahrling, P. B., & Jaax, N. K. (1997) · PubMed · Cited by 123
Iversen, P. L., Warren, T. K., Wells, J., Garza, N. L., Mourich, D. V., Welch, L. S., Panchal, R. G., & Bavari, S. (2012) · Viruses · doi:10.3390/v4112806 · Cited by 121
The pathology of experimental Ebola virus infection in monkeys
Baskerville, A., Bowen, E. T. W., Platt, G. S., et al. (1978) · The Journal of Pathology · doi:10.1002/path.1711250303 · Cited by 117
Liddell, A. M., Davey, R. T., Mehta, A. K., Varkey, J. B., Kraft, C. S., Tseggay, G. K., Badidi, O., Faust, A. C., Brown, K. V., Suffredini, A. F., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0530 · Cited by 114
Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis
Ryabchikova, E. I., Колесникова, Л. И., Smolina, M. I., Tkachev, V., Pereboeva, L., Баранова, С. Г., Grazhdantseva, A. A., & Rassadkin, Y. N. (1996) · Archives of Virology · doi:10.1007/bf01718165 · Cited by 104
Potential Mammalian Filovirus Reservoirs
Peterson, A. T., Carroll, D. S., Mills, J. N., & Johnson, K. M. (2004) · Emerging infectious diseases · doi:10.3201/eid1012.040346 · Cited by 104
Self-citationBlood kinetics of Ebola virus in survivors and nonsurvivors
Lanini, S., Portella, G., Vairo, F., Kobinger, G. P., Pesenti, A. M., Langer, M., Kabia, S., Brogiato, G., Amone, J., Castilletti, C., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83111 · Cited by 98
Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques
Twenhafel, N. A., Mattix, M. E., Johnson, J. C., Robinson, C. G., Pratt, W. D., Cashman, K. A., Wahl‐Jensen, V., Terry, C., Olinger, G. G., Hensley, L. E., et al. (2012) · Veterinary Pathology · doi:10.1177/0300985812469636 · Cited by 98
Strong, J. E., Wong, G., Jones, S. E., Grolla, A., Theriault, S., Kobinger, G., & Feldmann, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809698105 · Cited by 96
Self-citationBreman, J. G., Johnson, K. M., van der Groen, G., Robbins, C. B., Szczeniowski, M., Ruti, K., Webb, P. A., Meier, F., Heymann, D. L., & Teams, E. V. S. (1999) · The Journal of Infectious Diseases · doi:10.1086/514278 · Cited by 96
Self-citationDean, N. E., Halloran, M. E., Yang, Y., & Longini, I. M. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw114 · Cited by 94
Cytomegalovirus-associated protein-losing gastropathy in childhood
Megged, O., & Schlesinger, Y. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0791-1 · Cited by 91
The Marburg Virus Outbreak of 1967 and Subsequent Episodes
Slenczka, W. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_4 · Cited by 89
Molecular Basis for Ebolavirus VP35 Suppression of Human Dendritic Cell Maturation
Yen, B. C., Mulder, L. C. F., Martinez, O., & Basler, C. F. (2014) · Journal of Virology · doi:10.1128/jvi.02163-14 · Cited by 83
Successful Delivery of RRT in Ebola Virus Disease
Connor, M. J., Jr., Kraft, C. S., Mehta, A. K., Varkey, J. B., Lyon, G. M., Crozier, I., Ströher, U., Ribner, B. S., & Franch, H. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111057 · Cited by 78
Ajelli, M., Parlamento, S., Bome, D., Kebbi, A., Atzori, A., Frasson, C., Putoto, G., Carraro, D., & Merler, S. (2015) · BMC Medicine · doi:10.1186/s12916-015-0524-z · Cited by 76
Biologic Differences Between Strains of Ebola Virus from Zaire and Sudan
McCormick, J. B., Bauer, S. P., Elliott, L., Webb, P. A., & Johnson, K. M. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.2.264 · Cited by 74
Self-citationLi, J., Duan, H., Chen, H., Ji, Y., Zhang, X., Rong, Y.-H., Xu, Z., Sun, L., Zhang, J., Liu, L.-M., et al. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.10.021 · Cited by 73
Firsthand Clinical Observations of Hemorrhagic Manifestations in Ebola Hemorrhagic Fever in Zaire
Sureau, P. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s790 · Cited by 67
Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports: Table 1.
Caluwaerts, S., Fautsch, T., Lagrou, D., Moreau, M., Camara, A. M., Günther, S., Di, A., Borremans, B., Koundouno, F. R., Boré, J. A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1024 · Cited by 63
Faye, O., Andronico, A., Faye, O., Salje, H., Boëlle, P., Magassouba, N., Bah, E. I., Koivogui, L., Diallo, B., Diallo, A. A., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001908 · Cited by 62
Innate immune evasion by filoviruses
Basler, C. F. (2015) · Virology · doi:10.1016/j.virol.2015.03.030 · Cited by 61
Bower, H., Johnson, S., Bangura, M. S., Kamara, A. J., Kamara, O., Mansaray, S. H., Sesay, D., Turay, C., Checchi, F., & Glynn, J. R. (2016) · Emerging infectious diseases · doi:10.3201/eid2208.160163 · Cited by 61
Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis
Banadyga, L., Dolan, M. A., & Ebihara, H. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.008 · Cited by 61
Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells
Leung, L. W., Park, M., Martinez, O., Valmas, C., López, C. B., & Basler, C. F. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.169 · Cited by 60
Shedding of Ebola Virus in an Asymptomatic Pregnant Woman
Akerlund, E., Prescott, J. B., & Tampellini, L. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1503275 · Cited by 59
Antigenic Analysis of Strains of Ebola Virus: Identification of Two Ebola Virus Serotypes
Richman, D. D., Cleveland, P. H., McCormick, J. B., et al. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.2.268 · Cited by 57
Ebola virus disease candidate vaccines under evaluation in clinical trials
Martins, K. A. O., Jahrling, P. B., Bavari, S., & Kuhn, J. H. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1187566 · Cited by 53
Heffernan, R. T., Pambo, B., Hatchett, R. J., Leman, P. A., Swanepoel, R., & Ryder, R. W. (2005) · The Journal of Infectious Diseases · doi:10.1086/427994 · Cited by 50
The ebolavirus VP24 interferon antagonist
Zhang, A. P. P., Abelson, D. M., Bornholdt, Z. A., Liu, T., Woods, V. L., & Saphire, E. O. (2012) · Virulence · doi:10.4161/viru.21302 · Cited by 46
Edwards, K. M., Davis, J. E., Browne, K. A., Sutton, V. R., & Trapani, J. A. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00799.x · Cited by 40
Reverse genetics systems as tools for the development of novel therapies against filoviruses
Hoenen, T., & Feldmann, H. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.948848 · Cited by 36
Self-citationCournac, J. M., Karkowski, L., Bordes, J., Aletti, M., Duron, S., Janvier, F., Foissaud, V., Savini, H., de Greslan, T., Rousseau, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ779 · Cited by 36
Successful Control of Ebola Virus Disease: Analysis of Service Based Data from Rural Sierra Leone
Lokuge, K., Caleo, G., Greig, J. E., Duncombe, J., McWilliam, N., Squire, J. S., Lamin, M., Veltus, E. F., Wolz, A., Kobinger, G., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004498 · Cited by 34
Age-specific incidence of Ebola virus disease
Glynn, J. R. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61446-5 · Cited by 28
Host Factors in Ebola Infection
Rasmussen, A. L. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022446 · Cited by 18
Cardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus Disease
Chertow, D. S., Childs, R. W., Arai, A. E., & Davey, R. T. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.06.004 · Cited by 18
Self-citationPuzzling Origins of the Ebola Outbreak in the Democratic Republic of the Congo, 2014
Lam, T. T., Zhu, H., Chong, Y. L., Holmes, E. C., & Guan, Y. (2015) · Journal of Virology · doi:10.1128/jvi.01226-15 · Cited by 17
Protein-losing gastropathy associated with cytomegalovirus infection in a child
Russo, T., Costa, C., Crujo, C., & Lopes, A. I. (2012) · BMJ Case Reports · doi:10.1136/bcr.01.2012.5679 · Cited by 7
Cited by
Ibn-Mohammed, T., Mustapha, K. B., Godsell, J., Adamu, Z., Babatunde, K. A., Akintade, D. D., Acquaye, A., Fujii, H., Ndiaye, M. M., Yamoah, F. A., et al. (2021) · Resources, Conservation and Recycling · doi:10.1016/j.resconrec.2020.105169 · Cited by 862
Emerging Pandemic Diseases: How We Got to COVID-19
Morens, D. M., & Fauci, A. S. (2020) · Cell · doi:10.1016/j.cell.2020.08.021 · Cited by 716
Self-citationIba, T., Levy, J. H., Levi, M., & Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14975 · Cited by 585
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
Messner, C. B., Demichev, V., Wendisch, D., Michalick, L., White, M., Freiwald, A., Textoris-Taube, K., Vernardis, S. I., Egger, A.-S., Kreidl, M., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.05.012 · Cited by 561
Cao, Y.-C., Deng, Q.-X., & Dai, S.-X. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101647 · Cited by 320
Metadata
- Authors
- Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2017-01-24
- Volume
- 12
- Issue
- 1
- Pages
- 387-418
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2481228070
- Cited by
- 404
- References
- 142
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.